Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV005292996 | SCV005958737 | uncertain significance | Inborn genetic diseases | 2025-01-09 | criteria provided, single submitter | clinical testing | The c.2519T>G (p.V840G) alteration is located in exon 18 (coding exon 17) of the VPS13B gene. This alteration results from a T to G substitution at nucleotide position 2519, causing the valine (V) at amino acid position 840 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |